GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

While analysis of 18 identified biomarkers for adalimumab (Humira) initially yielded an AUC of 0.86 (95% CI 0.58-0.97), the ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

Pending: A vacant office block in Maidenhead could be turned into a large self-storage facility. Eurasia House in Concorde ...

Board Meeting Intimation for Board Meeting Intimation - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert ...

Gen Z's preference for convenient formats like gummies and effervescent powders, coupled with rising health awareness, is ...

UBS analyst Colin White maintained a Buy rating on Sanofi (SNYNF – Research Report) today. The company’s shares closed yesterday at $94.99. Don’t Miss TipRanks’ Half-Year ...

It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.

After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...

U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...